Engineering Nanorobots for Tumor‐Targeting Drug Delivery: From Dynamic Control to Stimuli‐Responsive Strategy

Lujia Huang,Fangmin Chen,Yi Lai,Zhiai Xu,Haijun Yu
DOI: https://doi.org/10.1002/cbic.202100347
IF: 3.2
2021-09-14
ChemBioChem
Abstract:Nanotechnology has been widely applied to the fabrication of drug delivery systems in the past few decades. Recently, with the progress made in the microfabrication approaches, nanorobots are steadily becoming promising approaches for tumor-targeting drug delivery. In general, nanorobots can be divided into two categories: nanomotors and stimuli-responsive nanorobots. Nanomotors are nanoscale systems with the ability to convert surrounding energies into mechanical motion, whereas stimuli-responsive nanorobots are featured with activatable capacity in response to various endogenous and exogenous stimulations. In this minireview, the dynamic control of nanomotors and the rational design of stimuli-responsive nanorobots are overviewed, with particular emphasis on their contribution to tumor-targeting therapy. Moreover, challenges and perspectives associated with the future development of nanorobots are also presented.
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?
The paper aims to address several key issues in tumor-targeted drug delivery. Specifically, it explores how nanorobot technology can enhance the precision and effectiveness of tumor treatment. The main focus areas include: 1. **Dynamic Control**: The paper discusses how to achieve autonomous movement and directional control of nanorobots through physical fields (such as light, ultrasound, magnetic fields, etc.) and chemical drives (such as hydrogen peroxide decomposition), to improve their penetration ability and drug release efficiency within tumor tissues. 2. **Stimulus-Responsive Strategies**: The paper introduces how to design nanorobots that can respond to specific signals in the tumor microenvironment (TME) (such as acidity, reducing agents, enzymes, etc.), thereby achieving targeted drug release and reducing side effects on normal tissues. 3. **Tumor Targeting**: The paper emphasizes the ability of nanorobots to actively target tumor cells by surface modification with specific ligands (such as folic acid, aptamers, etc.), enhancing drug accumulation and efficacy at the tumor site. 4. **Multifunctionality and Intelligence**: The paper also discusses the potential applications of nanorobots in tumor immunomodulation, in vivo imaging, and theranostics, showcasing their broad prospects in the field of precision medicine. In summary, the paper is dedicated to overcoming the limitations of traditional tumor drug delivery systems, such as the complexity of the tumor microenvironment, dose-limiting toxicity, and low patient response rates, through nanorobot technology, thereby improving the effectiveness and safety of tumor treatment.